Aggregated China Business Blogs



China Nepstar IPO Investors Get Their Drug Fix

Aggregated Source: China Stocks News and Analysis from Seeking Alpha
November 12, 2007|

Going into this week, China Nepstar (NYSE: NPD) had a price range on its public offering at $11.50-$13.50.  Well, as is usual for Chinese IPOs, it was too low. Thursday, China Nepstar priced its shares at $16 and as of this writing, the stock is up 17%.



Original URL: Click here to visit original article
Copyright China Stocks News and Analysis from Seeking Alpha
Print This Post Print This Post | Email This Page Email This Page
No Ratings Yet
Loading ... Loading ...

Related Info:
  • China Nepstar: A Drugstore Leader and Innovator
  • China Nepstar: A Great Growth Opportunity In China’s Pharmaceutical Market
  • China Nepstar Chain Drugstore Plans NYSE Listing
  • China Nepstar Chain Drugstore Reports 512.6% Increase In Net Income
  • China Nepstar Files Terms of Upcoming NYSE IPO

    • No Comments Yet »

    Your comment

    The following HTML tags are permitted:
    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    RSS RSS Feed for Comments on this Post |